Cargando…

Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection()

Respiratory syncytial virus (RSV) replication is primarily limited to the upper respiratory tract epithelium and primary, differentiated normal human bronchial epithelial cells (NHBE) have, therefore, been considered a good system for in vitro analysis of lung tissue response to respiratory virus in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harcourt, Jennifer L., Caidi, Hayat, Anderson, Larry J., Haynes, Lia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier/North-Holland Biomedical Press 2011
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112923/ https://www.ncbi.nlm.nih.gov/pubmed/21458491 http://dx.doi.org/10.1016/j.jviromet.2011.03.027

Ejemplares similares

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells
por: Harcourt, Jennifer L., et al.
Publicado: (2016)

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
por: Bakre, Abhijeet A., et al.
Publicado: (2017)

Binding of respiratory syncytial virus particles to platelets does not result in their degranulation in vitro
por: Lakerveld, Anke J., et al.
Publicado: (2023)

The prevalence of Middle East respiratory syndrome coronavirus (MERS‐CoV) antibodies in dromedary camels in Israel
por: Harcourt, Jennifer L., et al.
Publicado: (2018)

Human Respiratory Syncytial Virus and Streptococcus pneumoniae Infection in Wild Bonobos
por: Grützmacher, Kim S., et al.
Publicado: (2018)

Respiratory syncytial virus and other respiratory virus infections in residents of homeless shelters – King County, Washington, 2019–2021
por: McCulloch, Denise J., et al.
Publicado: (2023)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
por: Sande, Charles J., et al.
Publicado: (2014)

Immunofluorescence and molecular diagnosis of bovine respiratory syncytial virus and bovine parainfluenza virus in the naturally infected young cattle and buffaloes from India
por: Kamdi, Bhupesh, et al.
Publicado: (2020)

Respiratory syncytial virus seasonality in three epidemiological zones of Kenya
por: Rose, Erica Billig, et al.
Publicado: (2020)

Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany
por: Cai, Wei, et al.
Publicado: (2022)

The biennial cycle of respiratory syncytial virus outbreaks in Croatia
por: Mlinaric-Galinovic, Gordana, et al.
Publicado: (2008)

Relative timing of respiratory syncytial virus epidemics in summer 2021 across the United States was similar to a typical winter season
por: Zheng, Zhe, et al.
Publicado: (2022)

A survey strategy for human respiratory syncytial virus detection among haematopoietic stem cell transplant patients: epidemiological and methodological analysis
por: Moreira, Luciana Peniche, et al.
Publicado: (2013)

Recent sequence variation in probe binding site affected detection of respiratory syncytial virus group B by real-time RT-PCR
por: Kamau, Everlyn, et al.
Publicado: (2017)

Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines
por: Choi, Yoonyoung, et al.
Publicado: (2021)

Seasonal shift in epidemics of respiratory syncytial virus infection in Japan
por: Miyama, Takeshi, et al.
Publicado: (2021)

Functional Features of the Respiratory Syncytial Virus G Protein
por: Anderson, Larry J., et al.
Publicado: (2021)

Respiratory syncytial virus glycoproteins uptake occurs through clathrin-mediated endocytosis in a human epithelial cell line
por: Gutiérrez-Ortega, Abel, et al.
Publicado: (2008)

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro
por: Filipiak, Wojciech, et al.
Publicado: (2008)

Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis
por: Kusma, Jennifer D., et al.
Publicado: (2023)

Preliminary Studies on Validation of Calu-3 Cell Line as a Model for Screening Respiratory Mucosa Irritation and Toxicity
por: Ihekwereme, Chibueze, et al.
Publicado: (2014)

Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004–2008
por: Stockman, Lauren J., et al.
Publicado: (2013)

Genetic variability in G2 and F2 region between biological clones of human respiratory syncytial virus with or without host immune selection pressure
por: Moraes, Claudia Trigo Pedroso, et al.
Publicado: (2015)

Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro
por: Gao, Yuzhen, et al.
Publicado: (2021)

Evaluation of sequence hybridization for respiratory viruses using the Twist Bioscience Respiratory Virus Research panel and the OneCodex Respiratory Virus sequence analysis workflow
por: Kapel, Natalia, et al.
Publicado: (2023)

Structure-Guided Functional Characterization of Enediyne Self-Sacrifice Resistance Proteins, CalU16 and CalU19
por: Elshahawi, Sherif I., et al.
Publicado: (2014)

Respiratory syncytial virus - associated intensive care unit admission in children in Southern China
por: Zhang, Qingli, et al.
Publicado: (2013)

Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden
por: Pebody, Richard, et al.
Publicado: (2019)

In vitro and in vivo evaluation of cerium oxide nanoparticles in respiratory syncytial virus infection
por: Patel, Akhil, et al.
Publicado: (2022)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Respiratory Syncytial Virus Seasonality — United States, 2014–2017
por: Rose, Erica Billig, et al.
Publicado: (2018)

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants
por: DeVincenzo, John P., et al.
Publicado: (2016)

Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses
por: Trivedi, Suvang U., et al.
Publicado: (2019)

Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
por: Jorquera, Patricia A., et al.
Publicado: (2013)

Development and characterization of stable cell lines constitutively expressing the porcine reproductive and respiratory syndrome virus nucleocapsid protein
por: Sagong, Mingeun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5r7ci1f500ntnp9jvh0uq6r5dl